Quantitative Investment Management, LLC Esperion Therapeutics, Inc. Transaction History

Quantitative Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$30.04 - $51.31 $286,641 - $489,600	-9,542 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$27.44 - $73.84 $261,832 - $704,581	9,542 New	9,542 $300,000
Q1 2018 May 15, 2018	SELL	$65.94 - $80.76 $1.12 Million - $1.37 Million	-17,000 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$43.47 - $67.43 $4.63 Million - $7.19 Million	-106,600 Reduced 86.25%	17,000 $1.12 Million
Q3 2017 Nov 13, 2017	BUY	$43.8 - $52.77 $5.41 Million - $6.52 Million	123,600	123,600 $6.19 Million

217

127M

1.61M

1.1M

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $124M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Investment Management, LLC with notifications on news.